Inhibition of ICAM1 diminishes stemness and enhances antitumor immunity in glioblastoma via β-catenin/PD-L1 signaling.
Saved in:
| Title: | Inhibition of ICAM1 diminishes stemness and enhances antitumor immunity in glioblastoma via β-catenin/PD-L1 signaling. |
|---|---|
| Authors: | Guo M; Henan-Macquarie University Joint Centre for Biomedical Innovations, School of Life Sciences, Henan University, Kaifeng, Henan, China.; Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Kaifeng, Henan, China., Yuan Z; Henan-Macquarie University Joint Centre for Biomedical Innovations, School of Life Sciences, Henan University, Kaifeng, Henan, China.; Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Kaifeng, Henan, China., Jin X; Henan-Macquarie University Joint Centre for Biomedical Innovations, School of Life Sciences, Henan University, Kaifeng, Henan, China.; Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Kaifeng, Henan, China.; School of Pharmacy, Henan University, Kaifeng, Henan, China., Li X; Henan-Macquarie University Joint Centre for Biomedical Innovations, School of Life Sciences, Henan University, Kaifeng, Henan, China.; Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Kaifeng, Henan, China., Deng Y; Henan-Macquarie University Joint Centre for Biomedical Innovations, School of Life Sciences, Henan University, Kaifeng, Henan, China.; Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Kaifeng, Henan, China., Zhou S; Henan-Macquarie University Joint Centre for Biomedical Innovations, School of Life Sciences, Henan University, Kaifeng, Henan, China.; Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Kaifeng, Henan, China., Niu R; Henan-Macquarie University Joint Centre for Biomedical Innovations, School of Life Sciences, Henan University, Kaifeng, Henan, China.; Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Kaifeng, Henan, China., Bae J; Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Korea., Park JB; Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea., Shi B; Henan-Macquarie University Joint Centre for Biomedical Innovations, School of Life Sciences, Henan University, Kaifeng, Henan, China. bs@henu.edu.cn.; Faculty of Medicine & Health Sciences, Macquarie University, Sydney, NSW, Australia. bs@henu.edu.cn.; School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia. bs@henu.edu.cn., Yin J; Henan-Macquarie University Joint Centre for Biomedical Innovations, School of Life Sciences, Henan University, Kaifeng, Henan, China. jlyin@henu.edu.cn.; Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Kaifeng, Henan, China. jlyin@henu.edu.cn. |
| Source: | Nature communications [Nat Commun] 2025 Sep 30; Vol. 16 (1), pp. 8642. Date of Electronic Publication: 2025 Sep 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
